On March 31, Retrophin Inc (NASDAQ:RTRX) announced after the bell that it acquired all of Manchester Pharmaceuticals’ rights, titles and interests and related trademarks outside of the U.S to certain pharmaceutical products that contain the active ingredients chenodiol. The stock is now down 0.60 on 1.3 million shares. Retrophin Inc (NASDAQ:RTRX) shares after opening at $21.50 on last trade day and at the end of the day closed at $23.36. Company price to cash ratio in past twelve months was calculated as 32.87. Retrophin Inc (NASDAQ:RTRX) showed a positive weekly performance of 13.62%.
On March 11, Enzo Biochem, Inc.(NYSE:ENZ) reported across-the-board improved results for the fiscal second quarter ended January 31, 2014 as compared to the corresponding year-ago period. Total revenues improved 3%, with gains in Life Science and Clinical Labs, despite inclement winter weather that impacted laboratory revenues. Enzo Life Sciences operating results showed benefits of strategic realignment, including its emphasis on targeted markets with higher margin products. Enzo Biochem, Inc.(NYSE:ENZ) shares advanced 4.90% in last trading session and ended the day on $4.50. ENZ return on equity ratio is recorded as -48.70% and its return on assets is -29.40%. Enzo Biochem, Inc. (NYSE:ENZ) yearly performance is 97.37%.
The U.S. Supreme Court agreed to hear an appeal by Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) in a move that may delay generic competition to the company’s top-selling Copaxone multiple-sclerosis drug and alter how patent appeals are handled. Teva rose on the news. Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) shares moved up 0.47% in last trading session and was closed at $53.32, while trading in range of $53.05 – $54.70. Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) year to date (YTD) performance is 34.04%.
On Feb 6, 2014, Novadaq Technologies Inc. (NASDAQ:NVDQ) announced fourth quarter and full-year 2013 financial results. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States (U.S.) dollars. Novadaq Technologies Inc. (NASDAQ:NVDQ) weekly performance is 5.13%. On last trading day company shares ended up $23.56. Novadaq Technologies Inc. (NASDAQ:NVDQ) distance from 50-day simple moving average (SMA50) is 14.69%. Analysts mean target price for the company is $20.05.